Verona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript

Verona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript February 29, 2024

Verona Pharma plc beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23. VRNA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Welcome to Verona Pharma’s Fourth Quarter and Full Year Quarter 2023 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode....